Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO), effective March 31, 2023. David Patience, who previously served as Senior Director – Head of Business Development and Strategic Finance has been named as the company’s new CFO, effective April 1, 2023.
Reichling, who has been with the company since 2012, played a vital role in Accelerate Diagnostics’ growth and success over the years. During his tenure, he assisted with taking the company public in 2015, led all funding rounds, and held a key role in day-to-day operations of the company. Mr. Reichling will continue in a consulting role for the company through 2023. He is leaving the company to pursue new opportunities and challenges. “Steve has been an integral part of our team and has made significant contributions to our company’s growth and success,” said Jack Phillips, CEO of Accelerate Diagnostics. “We are grateful for his hard work and dedication, and we wish him all the best in his future endeavors.”
Steve Reichling commented, “A little over a decade ago, I joined Accelerate to bring much needed rapid testing to microbiology. And while there remains much to be done, I pass the baton to my friend and colleague David Patience confident that Accelerate is making a positive clinical impact today and has a bright future ahead. Recent progress on our capital structure, BD partnership, and next generation platform has set the company and its many stakeholders up for success. I would like to thank Jack Phillips, the hardworking team at Accelerate, and our broader community of supporters for making this incredible adventure possible.”
David Patience will take over as the company’s Chief Financial Officer, effective April 1, 2023. Mr. Patience will serve as the company’s principal financial officer and principal accounting officer. “We are delighted to have David take on this new role and are confident in his ability to lead our financial operations,” said Phillips. “He has been an instrumental part of our team, and we are eager to see how he will help us continue to grow and innovate in the years to come.”